30 July, 2014 by The TZ Newswire Staff Comments Off on Europe shares down ahead of data; Asia gains
Europe shares down ahead of data; Asia gains
European stocks were lower Wednesday ahead of U.S. economic data while cheery earnings from major Japanese companies such as Honda Motor Co. boosted Asian markets. KEEPING SCORE: In morning trade in Europe, …
30 July, 2014 by The TZ Newswire Staff Comments Off on Toyota remains at top in sales after first half
Toyota remains at top in sales after first half
Toyota remains No. 1 in global vehicles sales after the first six months of this year, followed by Volkswagen which bumped General Motors out of second place as the U.S. automaker grapples with a recall …
30 July, 2014 by The TZ Newswire Staff Comments Off on Russia’s central bank supports sanctions targets
Russia’s central bank supports sanctions targets
Russia’s central bank promised to support financial institutions hit by U.S. sanctions as stocks took a tumble in Moscow on Wednesday. In an online statement, the bank promised to “take adequate measures” …
30 July, 2014 by The TZ Newswire Staff Comments Off on Profit soaring after disgrace at onetime hedge fund
Profit soaring after disgrace at onetime hedge fund
Point72 Asset Management, the revamped firm of the billionaire investor Steven A. Cohen, generated a profit of nearly $1 billion for the first half.
30 July, 2014 by The TZ Newswire Staff Comments Off on Euro touches eight-month low, European shares fall
Euro touches eight-month low, European shares fall
The euro hit an eight-month trough against the dollar on Wednesday and German bond yields were at record lows ahead of inflation data expected to boost the case for further European Central Bank policy easing. Investors were also awaiting a statement from the Federal Reserve following its policy meeting that some expect to signal a more hawkish policy outlook, and data likely to show the U.S. economy bouncing back strongly in the second quarter.
30 July, 2014 by The TZ Newswire Staff Comments Off on AstraZeneca buys Almirall lung drugs for up to $2.1 billion
AstraZeneca buys Almirall lung drugs for up to $2.1 billion
AstraZeneca (AZN.L) took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall’s (ALM.MC) lung drugs. The British drugmaker, which resisted a $118 billion takeover attempt by Pfizer (PFE.N) in May, said it would pay an initial $875 million and up to $1.22 billion more if the drugs meet development and sales targets. The tie-up boosts a key therapeutic area for AstraZeneca, whose Chief Executive Pascal Soriot is determined to show his company has a strong independent future.
30 July, 2014 by The TZ Newswire Staff Comments Off on Relief rally? Russia markets shrug off sanctions
Relief rally? Russia markets shrug off sanctions
Russia’s MICEX Index rallied 2 percent in morning trade, despite news of the toughest sanctions against the country since the end of the Cold War.